5
UvA-DARE is a service provided by the library of the University of Amsterdam (http://dare.uva.nl) UvA-DARE (Digital Academic Repository) Mind the gap Bridging the difference between efficacy and effectiveness of orphan drugs Schuller, Y. Link to publication Creative Commons License (see https://creativecommons.org/use-remix/cc-licenses): Other Citation for published version (APA): Schuller, Y. (2018). Mind the gap: Bridging the difference between efficacy and effectiveness of orphan drugs. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. Download date: 29 Jun 2020

Creative Commons License (see ... · Mind the gap Bridging the difference between efficacy and effectiveness of orphan drugs ACADEMISCH PROEFSCHRIFT ter verkrijging van de graad van

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Creative Commons License (see ... · Mind the gap Bridging the difference between efficacy and effectiveness of orphan drugs ACADEMISCH PROEFSCHRIFT ter verkrijging van de graad van

UvA-DARE is a service provided by the library of the University of Amsterdam (http://dare.uva.nl)

UvA-DARE (Digital Academic Repository)

Mind the gapBridging the difference between efficacy and effectiveness of orphan drugsSchuller, Y.

Link to publication

Creative Commons License (see https://creativecommons.org/use-remix/cc-licenses):Other

Citation for published version (APA):Schuller, Y. (2018). Mind the gap: Bridging the difference between efficacy and effectiveness of orphan drugs.

General rightsIt is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s),other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).

Disclaimer/Complaints regulationsIf you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, statingyour reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Askthe Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam,The Netherlands. You will be contacted as soon as possible.

Download date: 29 Jun 2020

Page 2: Creative Commons License (see ... · Mind the gap Bridging the difference between efficacy and effectiveness of orphan drugs ACADEMISCH PROEFSCHRIFT ter verkrijging van de graad van

Mind the gap Bridging the diff

erence between effi

cacy and effectiveness of orphan drugs Yvonne Schuller

Bridging the difference between efficacy and effectiveness

of orphan drugs

Yvonne Schuller

Page 3: Creative Commons License (see ... · Mind the gap Bridging the difference between efficacy and effectiveness of orphan drugs ACADEMISCH PROEFSCHRIFT ter verkrijging van de graad van

Mind the gap

Bridging the difference between efficacy and effectiveness of orphan drugs

Y. Schuller

Page 4: Creative Commons License (see ... · Mind the gap Bridging the difference between efficacy and effectiveness of orphan drugs ACADEMISCH PROEFSCHRIFT ter verkrijging van de graad van

Colofon

© 2018, Yvonne Schuller, Amsterdam, The Netherlands

All rights reserved. No part of this thesis may be reproduced or transmitted in any form or by

any means, without permission of the author.

Work in this thesis was supported by the Dutch Medicines Evaluation Board (College ter

Beoordeling van Geneesmiddelen).

Financial support for the printing of this thesis was kindly provided by AMC Medical Research,

de Gaucher Stichting, Dutch Medicines Evaluation Board and ChipSoft.

ISBN 978-94-028-1054-7

Author Yvonne Schuller

Lay-out Ilse Stronks, persoonlijkproefschrift.nl

Cover Evelien Jagtman, www.evelienjagtman.com

Printing Ipskamp Printing

Mind the gap

Bridging the difference between efficacy and effectiveness of orphan drugs

ACADEMISCH PROEFSCHRIFT

ter verkrijging van de graad van doctor

aan de Universiteit van Amsterdam

op gezag van de Rector Magnificus

prof. dr. ir. K.I.J. Maex

ten overstaan van een door het College voor Promoties ingestelde commissie,

in het openbaar te verdedigen in de Agnietenkapel

op woensdag 4 juli 2018, te 10.00 uur

door Yvonne Schuller

geboren te Beverwijk

Page 5: Creative Commons License (see ... · Mind the gap Bridging the difference between efficacy and effectiveness of orphan drugs ACADEMISCH PROEFSCHRIFT ter verkrijging van de graad van

Promotiecommissie Promotor

Prof. dr. C.E.M. Hollak AMC - UvA

Copromotores

Dr. M. Biegstraaten AMC - UvA

Dr. V.V. Stoyanova-Beninska CBG-MEB

Overige leden

Prof. dr. B.M. Nogueira Sepodes University of Lisbon

Prof. dr. D. Cassiman UZ Leuven

Prof. dr. J.H.M. Schellens Antoni van Leeuwenhoek ziekenhuis

Dr. R.P. Hagendijk Universiteit van Amsterdam

Prof. dr. M.G.W. Dijkgraaf AMC - UvA

Prof. dr. M.J. Kersten AMC - UvA

Faculteit der Geneeskunde

Contents

Chapter 1 General introduction 7

Chapter 2 The quality of economic evaluations of ultra-orphan drugs in Europe –

a systematic review.

17

Chapter 3 Factors contributing to the efficacy-effectiveness gap in the case of

orphan drugs for metabolic diseases.

39

Chapter 4 Dose-finding studies among orphan drugs approved in the EU – a

retrospective analysis.

81

Chapter 5 Hurdles in access to high-priced orphan drugs. 113

Chapter 6 Adaptive pathway development for Fabry disease: a clinical approach. 143

Chapter 7 Oncologic orphan drugs approved in the EU – Do clinical trial data

correspond with real-world effectiveness?

159

Chapter 8 Clinical benefit of systemic treatment in patients with advanced

pancreatic and gastro-intestinal neuroendocrine tumors according to

ESMO-MCBS and ASCO framework.

193

Chapter 9 General discussion and future perspectives 217

Chapter 10 Addendum

Summary

Nederlandse Samenvatting

List of co-authors and affiliations

List of publications

List of acronyms and abbreviations

PhD Portfolio

About the author

Acknowledgements/Dankwoord

233

234

238

243

245

246

249

251

252